A blood-based metabolomics test to distinguish relapsing–remitting and secondary progressive multiple sclerosis: addressing practical considerations for clinical application

The transition from relapsing–remitting multiple sclerosis (RRMS) to secondary progressive MS (SPMS) represents a huge clinical challenge. We previously demonstrated that serum metabolomics could distinguish RRMS from SPMS with high diagnostic accuracy. As differing sample-handling protocols can aff...

Descripción completa

Detalles Bibliográficos
Autores principales: Yeo, Tianrong, Sealey, Megan, Zhou, Yifan, Saldana, Luisa, Loveless, Samantha, Claridge, Timothy D. W., Robertson, Neil, DeLuca, Gabriele, Palace, Jacqueline, Anthony, Daniel C., Probert, Fay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7381627/
https://www.ncbi.nlm.nih.gov/pubmed/32709911
http://dx.doi.org/10.1038/s41598-020-69119-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7381627/
https://www.ncbi.nlm.nih.gov/pubmed/32709911
http://dx.doi.org/10.1038/s41598-020-69119-3

Ejemplares similares